Shorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: Results from an exploratory study

Frontiers in Aging Neuroscience

Volumn 6, Issue AUG, 2014, Pages 1-31

  Marzetti, Emanuele ^a   Lorenzi, Maria ^a   Antocicco, Manuela ^a   Bonassi, Stefano ^b   Celi, Michela ^a   Mastropaolo, Simona ^a   Settanni, Silvana ^a   Valdiglesias, Vanessa ^c   Landi, Francesco ^a   Bernabei, Roberto ^a   Onder, Graziano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Bioelectrical impedance analysis; Biological age; Frailty; Inflammation; Muscle aging; Oxidative stress

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPLORATORY RESEARCH; FEMALE; GAIT; HAND STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE FUNCTION; MUSCLE MASS; OUTPATIENT DEPARTMENT; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; SARCOPENIA; SMOKING HABIT; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

EID: 84906237777     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00233     Document Type: Article

References (56)

1. Allsopp, R.C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E.V., Futcher, A.B., Greider, C.W., Harley, C.B. (1992). Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 89, 10114-10118. doi: 10.1073/pnas.89.21.10114.
2. Aubert, G., Lansdorp, P.M. (2008). Telomeres and aging. Physiol. Rev. 88, 557-579. doi: 10.1152/physrev.00026.2007.
3. Augustin, H., and Partridge, L. (2009) Invertebrate models of age-related muscle degeneration. Biochim. Biophys. Acta 1790, 1084-1094. doi: 10.1016/j.bbagen.2009.06.011.
4. Aviv, A. (2004). Telomeres and human aging: facts and fibs. Sci. Aging Knowledge Environ. 2004:pe43. doi: 10.1126/sageke.2004.51.pe43.
5. Bayne, S., and Liu, J.P. (2005). Hormones and growth factors regulate telomerase activity in ageing and cancer. Mol. Cell. Endocrinol. 240, 11-22.
6. Blackburn, E.H. (1991). Structure and function of telomeres. Nature 350, 569-573. doi: 10.1038/350569a0.
7. Blasco, M.A. (2005). Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6, 611-622. doi:10.1038/nrg1656.
8. Calvani, R., Joseph, A.M., Adhihetty, P.J., Miccheli, A., Bossola, M., Leeuwenburgh, C., Bernabei, R., Marzetti, E. (2013). Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol. Chem. 394, 393-414. doi: 10.1515/hsz-2012-0247.
9. Cawthon, R.M. (2002). Telomere measurement by quantitative PCR. Nucleic Acids Res. 30:e47. doi: 10.1093/nar/30.10.e47.
10. Cesari, M., Kritchevsky, S.B., Baumgartner, R.N., Atkinson, H.H., Penninx, B.W., Lenchik, L., Palla, S.L., Ambrosius, W.T., Tracy, R.P., Pahor, M. (2005). Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am. J. Clin. Nutr. 82, 428-434.
11. Chung, H.Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A.Y., Carter, C., Yu, B.P., Leeuwenburgh, C. (2009). Molecular inflammation: under pinnings of aging and age-related diseases. Ageing Res. Rev. 8, 18-30. doi: 10.1016/j.arr.2008.07.002.
12. Chung, H.Y., Sung, B., Jung, K.J., Zou, Y., Yu, B.P. (2006). The molecular inflammatory process in aging. Antioxid. Redox Signal. 8, 572-581. doi: 10.1089/ars.2006.8.572.
13. Collerton, J., Martin-Ruiz, C., Davies, K., Hilkens, C.M., Isaacs, J., Kolenda, C., Parker, C., Dunn, M., Catt, M., Jagger, C., von Zglinicki, T., Kirkwood, T.B. (2012). Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech. Ageing Dev. 133, 456-466. doi: 10.1016/j.mad.2012.05.005.
14. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., Martin, F.C., Michel, J.P., Rolland, Y., Schneider, S.M., Topinková, E., Vandewoude, M., Zamboni, M.; European Working Group on Sarcopenia in Older People. (2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412-423. doi: 10.1093/ageing/afq034.
15. Delmonico, M.J., Harris, T.B., Visser, M., Park, S.W., Conroy, M.B., Velasquez-Mieyer, P., Boudreau, R., Manini, T.M., Nevitt, M., Newman, A.B., Goodpaster, B.H.; Health, Aging, Body Composition Study. (2009). Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am. J. Clin. Nutr. 90, 1579-1585. doi: 10.3945/ajcn.2009.28047.
16. Epel, E.S., Blackburn, E.H., Lin, J., Dhabhar, F.S., Adler, N.E., Morrow, J.D., Cawthon, R.M. Accelerated telomere shortening in response to life stress. (2004). Proc. Natl. Acad. Sci. U. S. A. 101, 17312-17315. doi: 10.1073/pnas.0407162101.
17. Finkel, D., Whitfield, K., McGue, M. (1995). Genetic and environmental influences on functional age: a twin study. J. Gerontol. B Psychol. Sci. Soc. Sci. 50, P104-P113. doi: 10.1093/geronb/50B.2.P104.
18. Fisher, A.L. (2004). Of worms and women: sarcopenia and its role in disability and mortality. J. Am. Geriatr. Soc. 52, 1185-1190. doi: 10.1111/j.1532-5415.2004.52320.x.
19. Folstein, M.F., Folstein, S.E., McHugh, P.R. (1975). " Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
20. Fossel, M. (2012). Use of telomere length as a biomarker for aging and age-related disease. Curr. Transl. Geriatr. Exp. Gerontol. Rep. 1, 121-127. doi: 10.1007/s13670-012-0013-6.
21. Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W.J., Burke, G., McBurnie, M.A.; Cardiovascular Health Study Collaborative Research Group. (2001). Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56, M146-M156.
22. Frontera, W.R., Hughes, V.A., Lutz, K.J., Evans, W.J. (1991). A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J. Appl. Physiol. (1985). 71, 644-650.
23. Goggins, W.B., Woo, J., Sham, A., Ho, S.C. (2005). Frailty index as a measure of biological age in a Chinese population. J. Gerontol. A Biol. Sci. Med. Sci. 60, 1046-1051. doi: 10.1093/gerona/60.8.1046.
24. Grabowski, P., Hultdin, M., Karlsson, K., Tobin, G., Aleskog, A., Thunberg, U., Laurell, A., Sundström, C., Rosenquist, R., Roos, G. (2005). Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status. Blood 105, 4807-4812. doi: dx.doi.org/10.1182/blood-2004-11-4394.
25. Iannuzzi-Sucich, M., Prestwood, K.M., Kenny, A.M. (2002). Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J. Gerontol. A Biol. Sci. Med. Sci. 57, M772-M777.
26. Janssen, I., Heymsfield, S.B., Baumgartner, R.N., Ross, R. (2000). Estimation of skeletal muscle mass by bioelectrical impedance analysis. J. Appl. Physiol. (1985) 89, 465-471.
27. Katz, S., and Akpom, C.A. (1976). A measure of primary sociobiological functions. Int. J. Health Serv. 6, 493-508. doi: 10.2190/UURL-2RYU-WRYD-EY3K.
28. Kyle, U.G., Genton, L., Hans, D., Pichard, C. (2003). Validation of a bioelectrical impedance analysis equation to predict appendicular skeletal muscle mass (ASMM). Clin. Nutr. 22, 537-543. doi: 10.1016/S0261-5614(03)00048-7.
29. Lehmann, G., Muradian, K.K., Fraifeld, V.E. (2013). Telomere length and body temperature independent determinants of mammalian longevity? Front Genet. 4:111. doi: 10.3389/fgene.2013.00111.
30. Linn, B.S., Linn, M.W., Gurel. L. (1968). Cumulative illness rating scale. J. Am. Geriatr. Soc. 16, 622-626.
31. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. doi: 10.1006/meth.2001.1262.
32. Marzetti, E. (2012). Imaging, functional and biological markers for sarcopenia: The pursuit of the golden ratio. J. Frailty Aging 1, 97-98.
33. Marzetti, E., Calvani, R., Cesari, M., Buford, T.W., Lorenzi, M., Behnke, B.J., Leeuwenburgh, C. (2013). Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int. J. Biochem. Cell Biol. 45, 2288-2301. doi: 10.1016/j.biocel.2013.06.024.
34. Marzetti, E., Lees, H.A., Wohlgemuth, S.E., Leeuwenburgh, C. (2009). Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 35, 28-35. doi: 10.1002/biof.5.
35. Mikhelson, V.M., and Gamaley, I.A. (2012). Telomere shortening is a sole mechanism of aging in mammals. Curr. Aging Sci. 5, 203-208. doi: 10.2174/1874609811205030006.
36. Mitnitski, A.B., Graham, J.E., Mogilner, A.J., Rockwood, K. (2002). Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr. 2:1. doi:10.1186/1471-2318-2-1.
37. NIH Expert Panel. (1996). Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement. Am. J. Clin. Nutr. 64, 524S-532S.
38. O'Donovan, A., Pantell, M.S., Puterman, E., Dhabhar, F.S., Blackburn, E.H., Yaffe, K., Cawthon, R.M., Opresko, P.L., Hsueh, W.C., Satterfield, S., Newman, A. B., Ayonayon, H.N., Rubin, S.M., Harris, T.B., Epel, E.S.; Health Aging and Body Composition Study. (2011). Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS One 6:e19687. doi: 10.1371/journal.pone.0019687.
39. Payette, H., Roubenoff, R., Jacques, P.F., Dinarello, C.A., Wilson, P.W., Abad, L.W., Harris, T. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. (2003). J. Am. Geriatr. Soc. 51, 1237-1243. doi: 10.1046/j.1532-5415.2003.51407.x.
40. Pedersen, M., Bruunsgaard, H., Weis, N., Hendel, H.W., Andreassen, B.U., Eldrup, E., Dela, F., Pedersen, B.K. (2003). Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech. Ageing Dev. 124, 495-502. doi: 10.1016/S0047-6374(03)00027-7.
41. Richter, T., and von Zglinicki, T. (2007). A continuous correlation between oxidative stress and telomere shortening in fibroblasts. Exp. Gerontol. 42, 1039-1042. doi: 10.1016/j.exger.2007.08.005.
42. Rockwood, K., Andrew, M., Mitnitski, A. (2007). A comparison of two approaches to measuring frailty in elderly people. J. Gerontol. A Biol. Sci. Med. Sci. 62, 738-743.
43. Rockwood, K., Song, X., MacKnight, C., Bergman, H., Hogan, D.B., McDowell, I., Mitnitski, A. (2005). A global clinical measure of fitness and frailty in elderly people. CMAJ 173, 489-495. doi: 10.1503/cmaj.050051.
44. Rolland, Y., Czerwinski, S., Abellan Van Kan, G., Morley, J.E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., Chumlea, W.M., Vellas, B. (2008). Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J. Nutr. Health Aging 12, 433-450. doi: 10.1007/BF02982704.
45. Rothman, M.D., Leo-Summers, L., Gill, T.M. (2008). Prognostic significance of potential frailty criteria. J. Am. Geriatr. Soc. 56, 2211-2116. doi: 10.1111/j.1532-5415.2008.02008.x.
46. Roubenoff, R. (2000). Sarcopenia: a major modifiable cause of frailty in the elderly. J. Nutr. Health Aging 4, 140-142.
47. Searle, S.D., Mitnitski, A., Gahbauer, E.A., Gill, T.M., Rockwood, K. (2008). A standard procedure for creating a frailty index. BMC Geriatr. 8:24. doi: 10.1186/1471-2318-8-24.
48. Sheikh, J.I., and Yesavage, J.A. "Geriatric Depression Scale (GDS) Recent evidence and development of a shorter version". In: Brink, T.L. editor. Clinical Gerontology: A Guide to Assessment and Intervention. New York, NY: The Haworth Press (1986). p. 165-173.
49. Sprott, R.L. (2010). Biomarkers of aging and disease: introduction and definitions. Exp. Gerontol. 45, 2-4. doi: 10.1016/j.exger.2009.07.008.
50. Vasto, S., Scapagnini, G., Bulati, M., Candore, G., Castiglia, L., Colonna-Romano, G., Lio, D., Nuzzo, D., Pellicano, M., Rizzo, C., Ferrara, N., Caruso, C. (2010) Biomarkes of aging. Front. Biosci. (Schol Ed) 2:392-402. doi: 10.2741/72.
51. Visser, M., Pahor, M., Taaffe, D.R., Goodpaster, B.H., Simonsick, E.M., Newman, A.B., Nevitt, M., Harris, T.B. (2002). Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci. 57, M326-332. doi: 10.1093/gerona/57.5.M326.
52. Xi, H., Li, C., Ren, F., Zhang, H., Zhang, L. (2013). Telomere, aging and age-related diseases. Aging Clin. Exp. Res. 25, 139-146. doi: 10.1007/s40520-013-0021-1.
53. Washburn, R.A., Smith, K.W., Jette, A.M., Janney, C.A. (1993). The Physical Activity Scale for the Elderly (PASE): development and evaluation. J. Clin. Epidemiol. 46, 153-162.
54. Wong, J.Y., De Vivo, I., Lin, X., Fang, S.C., Christiani, D.C. (2014). The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study. PLoS One 9:e87348. doi: 10.1371/journal.pone.0087348.
55. Woo, J., Tang, N.L., Suen, E., Leung, J.C., Leung, P.C. (2008). Telomeres and frailty. Mech. Ageing Dev. 129, 642-648. doi: 10.1016/j.mad.2008.08.003.
56. Zhang, L., Du, J., Hu, Z., Han, G., Delafontaine, P., Garcia, G., Mitch, W.E. (2009). IL-6 and serum amyloid A synergy mediates angiotensin II- induced muscle wasting. J. Am. Soc. Nephrol. 20, 604-612. doi: 10.1681/ASN.2008060628.